Extension of Time to File SOU

TIVDAK

SEAGEN INC.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88130645
LAW OFFICE ASSIGNED LAW OFFICE 105
MARK SECTION
MARK TIVDAK (see, http://uspto.report/TM/88130645/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TIVDAK
OWNER SECTION (current)
NAME Seattle Genetics, Inc.
MAILING ADDRESS 21823 30th Drive S.E.
CITY Bothell
STATE Washington
ZIP/POSTAL CODE 98021
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
OWNER SECTION (proposed)
NAME Seattle Genetics, Inc.
MAILING ADDRESS 21823 30th Drive S.E.
CITY Bothell
STATE Washington
ZIP/POSTAL CODE 98021
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
ATTORNEY INFORMATION (current)
NAME John C. Baum
ATTORNEY BAR MEMBERSHIP NUMBER NOT SPECIFIED
YEAR OF ADMISSION NOT SPECIFIED
U.S. STATE/ COMMONWEALTH/ TERRITORY NOT SPECIFIED
FIRM NAME OWEN, WICKERSHAM & ERICKSON, P.C.
STREET 455 MARKET STREET, SUITE 1910
CITY SAN FRANCISCO
STATE California
POSTAL CODE 94105
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 415-882-3200
FAX 415-882-3232
EMAIL tmparalegal@owe.com
DOCKET/REFERENCE NUMBER SEATTLE00025
ATTORNEY INFORMATION (proposed)
NAME John C. Baum
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME OWEN, WICKERSHAM & ERICKSON, P.C.
STREET 455 MARKET STREET, SUITE 1910
CITY SAN FRANCISCO
STATE California
POSTAL CODE 94105
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 415-882-3200
FAX 415-882-3232
EMAIL tmparalegal@owe.com
DOCKET/REFERENCE NUMBER SEATTLE00025
OTHER APPOINTED ATTORNEY Gregory N. Owen, Lawrence G. Townsend, Linda Joy Kattwinkel, Spencer F. Owen, and Erin M. Clarke
CORRESPONDENCE INFORMATION (current)
NAME JOHN C. BAUM
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmparalegal@owe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jcbaum@owe.com
CORRESPONDENCE INFORMATION (proposed)
NAME John C. Baum
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmparalegal@owe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jcbaum@owe.com
DOCKET/REFERENCE NUMBER SEATTLE00025
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 10/29/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /John C. Baum/
SIGNATORY'S NAME John C. Baum
SIGNATORY'S POSITION Attorney of record, California Bar member
DATE SIGNED 04/03/2020
SIGNATORY'S PHONE NUMBER 415-882-3200
FILING INFORMATION
SUBMIT DATE Fri Apr 03 22:46:31 ET 2020
TEAS STAMP USPTO/ESU-XX.XXX.XX.XX-20
200403224631145536-881306
45-71056eb4e917e552a72de2
9955453a1f2694e5afa9cd915
9aac75385e4ea32934-DA-463
01240-2020040322432045520
5



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: TIVDAK (see, http://uspto.report/TM/88130645/mark.png)
SERIAL NUMBER: 88130645

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Seattle Genetics, Inc., having an address of
      21823 30th Drive S.E.
      Bothell, Washington 98021
      United States
Proposed: Seattle Genetics, Inc., having an address of
      21823 30th Drive S.E.
      Bothell, Washington 98021
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 10/29/2019.

For International Class 005:
Current identification: Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

The applicant's current Attorney Information:
      John C. Baum      OWEN, WICKERSHAM & ERICKSON, P.C.

      455 MARKET STREET, SUITE 1910
      SAN FRANCISCO, California 94105
      United States
      Phone: 415-882-3200
      Fax: 415-882-3232
      The docket/reference number is SEATTLE00025
      Email: tmparalegal@owe.com


The applicant's proposed Attorney Information:
      John C. Baum      OWEN, WICKERSHAM & ERICKSON, P.C.

      455 MARKET STREET, SUITE 1910
      SAN FRANCISCO, California 94105
      United States
      Phone: 415-882-3200
      Fax: 415-882-3232
      The docket/reference number is SEATTLE00025
      Email: tmparalegal@owe.com


Correspondence Information (current):
      JOHN C. BAUM
      PRIMARY EMAIL FOR CORRESPONDENCE: tmparalegal@owe.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jcbaum@owe.com

Correspondence Information (proposed):
      John C. Baum
      PRIMARY EMAIL FOR CORRESPONDENCE: tmparalegal@owe.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jcbaum@owe.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /John C. Baum/      Date Signed: 04/03/2020
Signatory's Name: John C. Baum
Signatory's Position: Attorney of record, California Bar member
Signatory's Phone: 415-882-3200

Mailing Address:
   OWEN, WICKERSHAM & ERICKSON, P.C.
   
   455 MARKET STREET, SUITE 1910
   SAN FRANCISCO, California 94105

RAM Sale Number: 88130645
RAM Accounting Date: 04/03/2020

Serial Number: 88130645
Internet Transmission Date: Fri Apr 03 22:46:31 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XX-20200403224631145
536-88130645-71056eb4e917e552a72de299554
53a1f2694e5afa9cd9159aac75385e4ea32934-D
A-46301240-20200403224320455205




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed